Beispiel: Heart Attack

Suchen Sie in klinischen Studien nach: Candesartan cilexetil

Insgesamt 180 ergebnisse

NCT02211638

Abgeschlossen

Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

Bedingungen: Hypertension
NCT02166697

Abgeschlossen

Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"

Bedingungen: Hypertension
NCT04012307

Abgeschlossen

The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting Conditions

Bedingungen: Bioequivalence
NCT01926652

Abgeschlossen

Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg

Bedingungen: Healthy
NCT01845272

Unbekannter Status

Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate

Bedingungen: Healthy
NCT02006602

Abgeschlossen

Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions

Bedingungen: Hypertension
NCT02006589

Abgeschlossen

Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions

Bedingungen: Hypertension
NCT04430959

Rekrutierung

Candesartan as an Adjunctive Treatment for Bipolar Depression

Bedingungen: Bipolar Disorder Depression
NCT02368652

Unbekannter Status

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

Bedingungen: Essential Hypertension
NCT03847506

Unbekannter Status

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets

Bedingungen: Hypertension, Hyperlipidemia
NCT00252733

Abgeschlossen

Diabetic Retinopathy Candesartan Trials

Bedingungen: Type 1 Diabetes
NCT01012479

Abgeschlossen

Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension

Bedingungen: Hypertension
NCT02016183

Abgeschlossen

Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

Bedingungen: Hypertension
NCT02064621

Abgeschlossen

CKD-330 Drug-Drug Interaction Study (Candesartan)

Bedingungen: Hypertension
NCT00621153

Abgeschlossen

Candesartan Effect in Second Stage Arterial Hypertension

Bedingungen: Stage II Hypertension
NCT02646982

Abgeschlossen

Candesartan's Effects on Alzheimer's Disease And Related Biomarkers

Bedingungen: Mild Cognitive Impairment
NCT00573430

Abgeschlossen

ARIA (Atacand Renoprotection In NephropAthy Pt.)

Bedingungen: Non-diabetic Nephropathy With Hypertension
NCT03136666

Abgeschlossen

Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design.

Bedingungen: Clinical Pharmacology
NCT00252694

Abgeschlossen

DIabetic Retinopathy Candesartan Trials

Bedingungen: Type 2 Diabetes
NCT00690612

Abgeschlossen

Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)

Bedingungen: Hypertension
NCT00252720

Abgeschlossen

DIabetic Retinopathy Candesartan Trials.

Bedingungen: Type 1 Diabetes
NCT04002440

Rekrutierung

Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight

Bedingungen: Efficacy; Safety Issues
NCT01788358

Abgeschlossen

Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension

Bedingungen: Hypertension
NCT00990639

Abgeschlossen

Effect of Candesartan in Alcoholic Liver Fibrosis

Bedingungen: Alcoholic Liver Disease
NCT02254447

Abgeschlossen

Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions

Bedingungen: Cardiovascular Disease